1847 Holdings restates ICU Eyewear FY2022/2021 financials; net loss reduced $3.6M

1847 Holdings LLC

2022 net loss restated from ($4.62M) to ($1.00M), driven by $3.62M impairment correction.
2021 total assets reduced by $2.98M due to restatement; accumulated deficit increased to ($31.43M).
ICU Eyewear FY2022 revenue $20.45M (2021: $22.03M including PPE); gross profit $6.39M.
Restatement corrects revenue recognition errors (customer allowances, chargebacks) under ASC 606.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.